Skip to main content
Print Save

Emtriva Prices, Coupons and Patient Assistance Programs

Emtriva (emtricitabine) is a member of the nucleoside reverse transcriptase inhibitors (NRTIs) drug class and is commonly used for HIV Infection, Nonoccupational Exposure, and Occupational Exposure.

Emtriva prices

The cost for Emtriva oral capsule 200 mg is around $574 for a supply of 30 capsules, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

A generic version of Emtriva has been approved by the FDA. However we either do not have pricing information for it, or it is not commercially available. More info: generic Emtriva availability

This Emtriva price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Oral Capsule

Oral Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Emtriva Coupons and Rebates

Emtriva offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Emtriva Advancing Access Co-pay Program: Eligible commercially insured patients may save up to $300 per month with a maximum savings of $3600 per year; for additional information contact the program at 800-226-2056.

Applies to:
Emtriva
Number of uses:
per prescription per year

Form more information phone: 800-226-2056 or Visit website

Patient Assistance Programs for Emtriva

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Advancing Access Program

Elligibility requirements:
  1. Must be uninsured or underinsured
  2. At or below 500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must be residing in the US or Puerto Rico
  5. This program is for outpatient use only. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. This Program participates in the CPAPA. This single common application allows uninsured HIV-positive individuals with low incomes to use one application to apply for multiple assistance programs. *IMPORTANT: Send completed CPAPA to the corresponding addresses listed for each company.
Applicable drugs:
  • Emtriva (emtricitabine)

More information please phone: 800-226-2056 Visit Website

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Emtriva (emtricitabine)

More information please phone: 866-316-7263 Visit Website

Provider: Good Days Program

Elligibility requirements:
  1. Must have insurance
  2. At or below 500% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be a US resident with a Social Security Number.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
Applicable drugs:
  • Emtriva (emtricitabine)

More information please phone: 877-968-7233 Visit Website